tiprankstipranks
Atara Biotherapeutics Inc (ATRA)
NASDAQ:ATRA
US Market
ATRA
Atara Biotherapeutics
RESEARCH TOOLSreports
Want to see ATRA full AI Analyst Report?

Atara Biotherapeutics (ATRA) Ratios

1,201 Followers

Atara Biotherapeutics Ratios

ATRA's free cash flow for Q4 2025 was $0.93. For the 2025 fiscal year, ATRA's free cash flow was decreased by $ and operating cash flow was $-2.46. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 0.82 0.82 0.48 0.72 3.74
Quick Ratio
 0.82 0.82 0.40 0.65 3.72
Cash Ratio
 0.57 0.57 0.19 0.18 1.18
Solvency Ratio
 0.59 0.57 -0.39 -1.02 -0.89
Operating Cash Flow Ratio
 -3.41 -3.41 -0.51 -1.36 -3.43
Short-Term Operating Cash Flow Coverage
 -4.73 -4.73 0.00 0.00 0.00
Net Current Asset Value
$ -46.52M$ -46.52M$ -141.49M$ -162.87M$ 45.30M
Leverage Ratios
Debt-to-Assets Ratio
 2.61 2.61 0.40 0.35 0.19
Debt-to-Equity Ratio
 -1.37 -1.37 -0.45 -0.58 0.57
Debt-to-Capital Ratio
 3.69 3.69 -0.82 -1.40 0.36
Long-Term Debt-to-Capital Ratio
 -5.61 -5.61 0.00 0.00 0.00
Financial Leverage Ratio
 -0.53 -0.53 -1.12 -1.67 2.97
Debt Service Coverage Ratio
 2.56 3.46 -16.41 -50.33 -595.91
Interest Coverage Ratio
 9.46 9.46 -18.08 -52.22 -752.05
Debt to Market Cap
 1.06 0.19 0.00 0.00 0.00
Interest Debt Per Share
 4.51 4.51 6.47 14.91 17.67
Net Debt to EBITDA
 1.19 0.88 -0.25 -0.12 0.10
Profitability Margins
Gross Profit Margin
82.44%82.44%83.71%-3.65%100.00%
EBIT Margin
29.07%30.23%-62.66%-3159.06%-358.51%
EBITDA Margin
30.86%41.74%-58.75%-3102.73%-349.62%
Operating Profit Margin
29.69%29.69%-64.71%-3219.48%-441.25%
Pretax Profit Margin
27.09%27.09%-66.24%-3220.70%-359.10%
Net Profit Margin
27.07%27.07%-66.23%-3220.88%-359.12%
Continuous Operations Profit Margin
27.07%27.07%-66.23%-3220.88%-359.12%
Net Income Per EBT
99.91%99.91%99.99%100.01%100.01%
EBT Per EBIT
91.24%91.24%102.37%100.04%81.38%
Return on Assets (ROA)
161.54%161.54%-78.28%-166.84%-60.65%
Return on Equity (ROE)
-79.12%-84.90%87.79%278.27%-180.28%
Return on Capital Employed (ROCE)
674.99%674.99%327.52%-1185.69%-94.29%
Return on Invested Capital (ROIC)
222.66%222.66%721.74%-778.42%-90.16%
Return on Tangible Assets
161.54%161.54%-78.28%-166.84%-60.65%
Earnings Yield
52.22%14.41%-85.69%-508.41%-68.25%
Efficiency Ratios
Receivables Turnover
 96.39 96.39 87.00 0.25 1.58
Payables Turnover
 167.02 167.02 4.81 2.41 0.00
Inventory Turnover
 0.00 0.00 1.97 0.92 0.00
Fixed Asset Turnover
 16.92 16.92 3.14 0.15 0.86
Asset Turnover
 5.97 5.97 1.18 0.05 0.17
Working Capital Turnover Ratio
 -103.44 -3.34 -2.34 0.10 0.26
Cash Conversion Cycle
 1.60 1.60 113.44 1.70K 230.93
Days of Sales Outstanding
 3.79 3.79 4.20 1.45K 230.93
Days of Inventory Outstanding
 0.00 0.00 185.11 398.68 0.00
Days of Payables Outstanding
 2.19 2.19 75.87 151.32 0.00
Operating Cycle
 3.79 3.79 189.31 1.85K 230.93
Cash Flow Ratios
Operating Cash Flow Per Share
 -4.06 -4.06 -9.18 -45.55 -66.29
Free Cash Flow Per Share
 -4.06 -4.06 -9.21 -45.84 -67.32
CapEx Per Share
 0.00 0.00 0.03 0.29 1.03
Free Cash Flow to Operating Cash Flow
 1.00 1.00 1.00 1.01 1.02
Dividend Paid and CapEx Coverage Ratio
 0.00 0.00 -279.34 -157.79 -64.50
Capital Expenditure Coverage Ratio
 0.00 0.00 -279.34 -157.79 -64.50
Operating Cash Flow Coverage Ratio
 -0.96 -0.96 -1.57 -3.33 -3.77
Operating Cash Flow to Sales Ratio
 -0.42 -0.42 -0.53 -22.51 -4.25
Free Cash Flow Yield
-124.83%-22.45%-69.19%-357.57%-82.09%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 1.92 6.94 -1.17 -0.20 -1.47
Price-to-Sales (P/S) Ratio
 0.34 1.88 0.77 6.34 5.26
Price-to-Book (P/B) Ratio
 -1.63 -5.89 -1.02 -0.55 2.64
Price-to-Free Cash Flow (P/FCF) Ratio
 -0.80 -4.45 -1.45 -0.28 -1.22
Price-to-Operating Cash Flow Ratio
 -1.23 -4.45 -1.45 -0.28 -1.24
Price-to-Earnings Growth (PEG) Ratio
 <0.01 -0.06 0.01 -0.01 0.04
Price-to-Fair Value
 -1.63 -5.89 -1.02 -0.55 2.64
Enterprise Value Multiple
 2.29 5.38 -1.56 -0.32 -1.41
Enterprise Value
 85.12M 271.24M 118.47M 86.34M 313.29M
EV to EBITDA
 2.28 5.38 -1.56 -0.32 -1.41
EV to Sales
 0.70 2.25 0.92 10.07 4.93
EV to Free Cash Flow
 -1.67 -5.32 -1.72 -0.44 -1.14
EV to Operating Cash Flow
 -1.67 -5.32 -1.72 -0.45 -1.16
Tangible Book Value Per Share
 -3.07 -3.07 -12.99 -23.42 31.04
Shareholders’ Equity Per Share
 -3.07 -3.07 -12.99 -23.42 31.04
Tax and Other Ratios
Effective Tax Rate
 <0.01 <0.01 <0.01 >-0.01 >-0.01
Revenue Per Share
 9.63 9.63 17.22 2.02 15.58
Net Income Per Share
 2.61 2.61 -11.41 -65.18 -55.96
Tax Burden
 1.00 1.00 1.00 1.00 1.00
Interest Burden
 0.93 0.90 1.06 1.02 1.00
Research & Development to Revenue
 0.31 0.31 1.17 26.22 4.29
SG&A to Revenue
 0.21 0.22 0.31 5.94 1.13
Stock-Based Compensation to Revenue
 0.08 0.08 0.21 5.29 0.85
Income Quality
 -1.56 -1.56 0.80 0.70 1.18
Currency in USD